Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

Abroad (travel likely)Recruiting

Conditions

Cytomegalovirus Infections · CMV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hematology Department, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Xiaojin Wu, Prof.) · wuxiaojin@suda.edu.cn · 13057493105

Study leads

Xiaojin Wu, Prof.
Principal Investigator
The First Affiliated Hospital of Soochow University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Cytomegalovirus Infections · Kidney Transplant Infection · Pancreas Transplant

Abroad (travel likely)RecruitingPHASE3

Madison, United States

Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir

Pregnant Women · CMV Infected Fetuses

Abroad (travel likely)RecruitingPHASE3

Paris, France

Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients

CMV · Lung Transplant Recipient

Abroad (travel likely)RecruitingPHASE4

Toronto, Canada

Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections

Cytomegalovirus Infection

Abroad (travel likely)RecruitingPHASE3

Paris, France · Paris, France